Cytokines secreted by tumor cells could stimulate osteoclasts and subsequently activate the NF‐κB (RANK)/RANK ligand (RANKL) pathway, which is related to the effectiveness of checkpoint blockade in cancer treatment [17, 18]. The gene discussed is TNFSF11; the disease is neoplasm.